RU2302240C2 - Производные карбаматов для предотвращения или лечения психотических нарушений - Google Patents

Производные карбаматов для предотвращения или лечения психотических нарушений Download PDF

Info

Publication number
RU2302240C2
RU2302240C2 RU2003128983/14A RU2003128983A RU2302240C2 RU 2302240 C2 RU2302240 C2 RU 2302240C2 RU 2003128983/14 A RU2003128983/14 A RU 2003128983/14A RU 2003128983 A RU2003128983 A RU 2003128983A RU 2302240 C2 RU2302240 C2 RU 2302240C2
Authority
RU
Russia
Prior art keywords
formula
group
disorder
enantiomer
psychotic
Prior art date
Application number
RU2003128983/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2003128983A (ru
Inventor
Карлос Р. ПЛАТА-САЛАМАН (US)
Карлос Р. Плата-Саламан
Бою ЗАО (US)
Бою ЗАО
Рой Э. ТУАЙМЭН (US)
Рой Э. ТУАЙМЭН
Original Assignee
Орто-Макнейл Фармасьютикал, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орто-Макнейл Фармасьютикал, Инк. filed Critical Орто-Макнейл Фармасьютикал, Инк.
Publication of RU2003128983A publication Critical patent/RU2003128983A/ru
Application granted granted Critical
Publication of RU2302240C2 publication Critical patent/RU2302240C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2003128983/14A 2001-02-27 2002-02-21 Производные карбаматов для предотвращения или лечения психотических нарушений RU2302240C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US60/271,889 2001-02-27
US10/081,761 2002-02-21
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
RU2003128983A RU2003128983A (ru) 2005-03-10
RU2302240C2 true RU2302240C2 (ru) 2007-07-10

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003128983/14A RU2302240C2 (ru) 2001-02-27 2002-02-21 Производные карбаматов для предотвращения или лечения психотических нарушений

Country Status (25)

Country Link
US (1) US6541513B2 (https=)
EP (1) EP1401424B1 (https=)
JP (1) JP4276841B2 (https=)
KR (1) KR100886578B1 (https=)
CN (1) CN1262271C (https=)
AR (1) AR032876A1 (https=)
AT (1) ATE346597T1 (https=)
AU (1) AU2002242296B2 (https=)
BR (1) BR0207829A (https=)
CA (1) CA2439480C (https=)
CZ (1) CZ302412B6 (https=)
DE (1) DE60216457T2 (https=)
DK (1) DK1401424T3 (https=)
ES (1) ES2275844T3 (https=)
HU (1) HUP0303342A3 (https=)
IL (2) IL157588A0 (https=)
MX (1) MXPA03007722A (https=)
NO (1) NO20033801L (https=)
NZ (1) NZ527991A (https=)
PL (1) PL365021A1 (https=)
PT (1) PT1401424E (https=)
RS (1) RS51056B (https=)
RU (1) RU2302240C2 (https=)
TW (1) TWI251486B (https=)
WO (1) WO2002067927A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE267629T1 (de) * 2000-07-21 2004-06-15 Ortho Mcneil Pharm Inc Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen
EP1383489B1 (en) * 2001-02-27 2007-05-09 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
IL157594A0 (en) 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating anxiety disorders
ATE435014T1 (de) 2001-07-16 2009-07-15 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
ES2385087T3 (es) * 2005-07-26 2012-07-18 Sk Biopharmaceuticals Co., Ltd Procedimientos para tratar trastornos relacionados con sustancias
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
BRPI0718323A2 (pt) * 2006-10-31 2013-11-26 Janssen Pharmaceutica Nv Tratamento de transtornos invasivos do desenvolvimento.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN105189451A (zh) * 2013-03-12 2015-12-23 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2023712C1 (ru) * 1989-06-09 1994-11-30 Дзе Апджон Компани Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2023712C1 (ru) * 1989-06-09 1994-11-30 Дзе Апджон Компани Трициклические азотсодержащие соединения и производные тетрагидрохинолина или их фармацевтически приемлемые соли
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
КАПЛАН Г. и др. Клиническая психиатрия. - М.: ГЭОТАР МЕДИЦИНА, 1994, с.124. VOVIN R.Ia. et al. Effectiveness of finlepsin in the prophylactic therapy of phasic affective psychoses. Zh Nevropatol Psikhiatr Im S S Korsakova. 1987; 87(9):1396-400. *
Психиатрия. / Под ред. Р.Шейдера. - М.: Практика, 1998, с.420. *

Also Published As

Publication number Publication date
TWI251486B (en) 2006-03-21
NZ527991A (en) 2005-04-29
HUP0303342A2 (hu) 2004-01-28
EP1401424A1 (en) 2004-03-31
ATE346597T1 (de) 2006-12-15
DE60216457D1 (de) 2007-01-11
KR100886578B1 (ko) 2009-03-05
DE60216457T2 (de) 2007-09-20
NO20033801L (no) 2003-10-22
EP1401424B1 (en) 2006-11-29
RS67503A (sr) 2006-12-15
CA2439480A1 (en) 2002-09-06
PT1401424E (pt) 2007-02-28
IL157588A0 (en) 2004-03-28
US20020165272A1 (en) 2002-11-07
CZ20032297A3 (cs) 2004-06-16
CN1262271C (zh) 2006-07-05
MXPA03007722A (es) 2004-11-12
CA2439480C (en) 2011-04-26
KR20030076713A (ko) 2003-09-26
DK1401424T3 (da) 2007-02-26
BR0207829A (pt) 2004-06-22
WO2002067927A1 (en) 2002-09-06
PL365021A1 (en) 2004-12-27
JP4276841B2 (ja) 2009-06-10
ES2275844T3 (es) 2007-06-16
IL157588A (en) 2009-12-24
US6541513B2 (en) 2003-04-01
AR032876A1 (es) 2003-11-26
RS51056B (sr) 2010-10-31
NO20033801D0 (no) 2003-08-26
JP2004523556A (ja) 2004-08-05
RU2003128983A (ru) 2005-03-10
CN1505507A (zh) 2004-06-16
AU2002242296B2 (en) 2006-06-29
CZ302412B6 (cs) 2011-05-04
HUP0303342A3 (en) 2012-07-30

Similar Documents

Publication Publication Date Title
RU2302240C2 (ru) Производные карбаматов для предотвращения или лечения психотических нарушений
KR101335941B1 (ko) 수면-각성 장애의 치료
KR20120080656A (ko) 주의력 결핍/과잉행동 장애(ａｄｈｄ)의 치료 방법
JP2008542378A (ja) 精神病性障害を管理する方法および組成物
JP2010531879A (ja) 水素化ピリド［４，３−ｂ］インドールに基づく抗不安作用を示す薬物、その薬理学的な化合物および適用方法
RU2294739C2 (ru) Производные карбамата для применения для предупреждения или лечения расстройств движений
JP2005523334A (ja) ストレス関連障害を含む機能的身体障害の予防および処置
TW202327572A (zh) 用於輔助心理治療的ｒ－ｍｄｍａ和ｓ－ｍｄｍａ
HK1247847A1 (zh) 四氢-N，N-二甲基-2，2-二苯基-3-呋喃甲胺的对映体(ANAVEX2-73)及其在治疗阿尔海默氏病和其他由σ1受体调节的疾病中的用途
US20250122164A1 (en) N,n-dimethylamphetamine analogs for treating brain disorders
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
KR20080089414A (ko) 우울증 치료를 위한 벤조-융합된 헤테로사이클 설파미드유도체의 용도
RS51790B (sr) Upotreba derivata benzo-kondenzovanih heterocikličkih sulfamida za lečenje manije i bipolarnog poremećaja
EA015566B1 (ru) Применение пептидного соединения для добавочной терапии к антагонисту дофамина и фармацевтическая композиция, его содержащая
DE60210960T2 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
CN101272776B (zh) 氨基甲酸酯在制备治疗物质滥用相关疾病药物中的用途
US20060167026A1 (en) Antipsychotic molecular-targeting epithelial growth factor receptor
CA3179105A1 (en) The combination of acetyl leucine and 4-aminopyridine or acetazolamide for treating ataxia
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
HK1209058B (en) Compositions for treating drug addiction and improving addiction-related behavior

Legal Events

Date Code Title Description
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20190207

PD4A Correction of name of patent owner
PC41 Official registration of the transfer of exclusive right

Effective date: 20190506